Cardinal Health, Inc. Website

Cardinal Health, Inc.

NYSE-CAH

Income Statement
Jun '15
Jun '16
Jun '17
Jun '18
Jun '19
Jun '20
Jun '21
Jun '22
Jun '23
Jun '24

Total Revenues

152,922

162,467

181,326

204,979

226,827

Total Revenues % Chg.

5.1%

6.2%

11.6%

13%

10.7%

Cost of Goods Sold, Total

146,054

155,689

174,842

198,105

219,413

Gross Profit

6,868

6,778

6,484

6,874

7,414

Selling General & Admin Expenses, Total

4,572

4,533

4,512

4,800

5,000

Amortization of Goodwill and Intangible Assets

524

451

324

285

268

Other Operating Expenses, Total

5,096

4,984

4,836

5,085

5,268

Operating Income

1,772

1,794

1,648

1,789

2,146

Interest Expense, Total

-238

-180

-147

-78

-77

Net Interest Expenses

-238

-180

-147

-78

-77

Currency Exchange Gains (Loss)

-11

-8

—

-13

27

Other Non Operating Income (Expenses)

12

55

-22

2

8

EBT, Excl. Unusual Items

1,535

1,661

1,479

1,700

2,104

Restructuring Charges

-122

-114

-101

-95

-175

Merger & Related Restructuring Charges

—

—

—

—

—

—

—

-16

Impairment of Goodwill

—

—

—

—

—

—

-2,100

-1,200

-675

Gain (Loss) On Sale Of Investments

—

—

—

—

—

579

-2

2

—

—

Gain (Loss) On Sale Of Assets

—

—

—

—

—

-60

—

—

—

Asset Writedown

-7

-19

40

-46

41

Legal Settlements

-5,741

-1,129

-94

304

-78

Other Unusual Items

—

—

-16

-14

-10

—

—

EBT, Incl. Unusual Items

-3,772

323

-784

663

1,201

Income Tax Expense

-79

-289

153

332

348

Earnings From Continuing Operations

-3,693

612

-937

331

853

Earnings Of Discontinued Operations

—

—

—

—

—

—

—

—

—

Minority Interest

—

-3

-1

-1

-1

-1

Net Income

-3,696

611

-938

330

852

Net Income to Common Incl Extra Items

-3,696

611

-938

330

852

Net Income to Common Excl. Extra Items

-3,696

611

-938

330

852

Total Shares Outstanding

293

291

273

251

244

Weighted Avg. Shares Outstanding

293

292

279

261

245

Weighted Avg. Shares Outstanding Dil

293

294

279

262

247

EPS

-12.6

2.1

-3.4

1.3

3.5

EPS Diluted

-12.6

2.1

-3.4

1.3

3.5

EBITDA

2,685

2,577

2,340

2,481

2,856

Effective Tax Rate

2.1%

-89.5%

-19.5%

50.1%

29%